Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-017995

Chair and CEO sold 6,830 shares at an average $70.16 ($479,177)

  • Chair and CEO acquired 6,830 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-15 Exercise or conversion : show line 1 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-04-15 Sale : show line 2 in the form 10b5-1 −3,334 $69.62 $232,113 237,420 I
2025-04-15 Sale : show line 3 in the form 10b5-1 −2,896 $70.54 $204,284 234,524 I
2025-04-15 Sale : show line 4 in the form 10b5-1 −600 $71.30 $42,780 233,924 I
Open-market sales · 6,830 sh · avg $70.16 · $479,177

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-15 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −6,830 177,650 I
Loading xslF345X05/wk-form4_1744834668.xml…